{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:53:35Z","timestamp":1777593215351,"version":"3.51.4"},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,9,15]]},"DOI":"10.2169\/internalmedicine.6734-20","type":"journal-article","created":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T22:06:49Z","timestamp":1616969209000},"page":"2879-2885","source":"Crossref","is-referenced-by-count":2,"title":["Comparative Analysis of the Attitudes toward Palliative Care between Medical Oncologists and Pulmonologists"],"prefix":"10.2169","volume":"60","author":[{"given":"Tamio","family":"Okimoto","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Medical Oncology and Respiratory Medicine, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Tsubata","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Medical Oncology and Respiratory Medicine, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Medical Oncology and Respiratory Medicine, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Hotta","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Medical Oncology and Respiratory Medicine, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Hamaguchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Medical Oncology and Respiratory Medicine, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Hamaguchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Medical Oncology and Respiratory Medicine, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Isobe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Medical Oncology and Respiratory Medicine, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Ministry of Health LaW. Vital Statistics Japan 2018."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 45: 884-891, 2015.","DOI":"10.1093\/jjco\/hyv088"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Katanoda K, Hori M, Matsuda T, et al. An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013. Jpn J Clin Oncol 45: 390-401, 2015.","DOI":"10.1093\/jjco\/hyv002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363: 733-742, 2010.","DOI":"10.1056\/NEJMoa1000678"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hanna N, Johnson D, Temin S, et al. Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35: 3484-3515, 2017.","DOI":"10.1200\/JCO.2017.74.6065"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Smith TJ, Temin S, Alesi ER, et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30: 880-887, 2012.","DOI":"10.1200\/JCO.2011.38.5161"},{"key":"7","unstructured":"7. American Academy of Hospice and Palliative Medicine. Hospice and palliative medicine physicians [Internet]. 2019 [cited 2020 Jun 1]. Available from: http:\/\/aahpm.org\/career\/workforce-study#HPMphysicians"},{"key":"8","unstructured":"8. Japanese Society for Palliative Medicine. Board certified fellow of the Japanese Society for Palliative Medicine [Internet]. 2020 [cited 2020 Jun 1]. Available from: https:\/\/www.jspm.ne.jp\/nintei\/list_menu.html  (in Japanese)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Devi PS. A timely referral to palliative care team improves quality of life. Indian J Palliat Care 17: S14-S16, 2011.","DOI":"10.4103\/0973-1075.76233"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Greer JA, Pirl WF, Jackson VA, et al. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol 30: 394-400, 2012.","DOI":"10.1200\/JCO.2011.35.7996"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Odagiri T, Morita T, Aoyama M, et al. Families' sense of abandonment when patients are referred to hospice. Oncologist 23: 1109-1115, 2018.","DOI":"10.1634\/theoncologist.2017-0547"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Morita T, Akechi T, Ikenaga M, et al. Late referrals to specialized palliative care service in Japan. J Clin Oncol 23: 2637-2644, 2005.","DOI":"10.1200\/JCO.2005.12.107"},{"key":"13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1634\/theoncologist.2011-0219","volume":"17","author":"E Bruera","year":"2012","unstructured":"13. Bruera E, Yennurajalingam S. Palliative care in advanced cancer patients: how and when? The Oncologist 17: 267-273, 2012.","journal-title":"The Oncologist","ISSN":"https:\/\/id.crossref.org\/issn\/1083-7159","issn-type":"print"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hui D, Parsons H, Nguyen L, et al. Timing of palliative care referral and symptom burden in phase 1 cancer patients: a retrospective cohort study. Cancer 116: 4402-4409, 2010.","DOI":"10.1002\/cncr.25389"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Salins N, Patra L, Usha Rani MR, et al. Integration of early specialist palliative care in cancer care: survey of oncologists, oncology nurses, and patients. Indian J Palliat Care 22: 258-265, 2016.","DOI":"10.4103\/0973-1075.185030"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Komiya T, Mackay CB, Chalise P. Who treats lung cancer? Results from a global survey. Respir Investig 55: 308-313, 2017.","DOI":"10.1016\/j.resinv.2017.07.002"},{"key":"17","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1634\/theoncologist.2015-0240","volume":"20","author":"D Hui","year":"2015","unstructured":"17. Hui D, Park M, Liu D, Reddy A, Dalal S, Bruera E. Attitudes and beliefs toward supportive and palliative care referral among hematologic and solid tumor oncology specialists. The Oncologist 20: 1326-1332, 2015.","journal-title":"The Oncologist","ISSN":"https:\/\/id.crossref.org\/issn\/1083-7159","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplantat 48: 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"19","unstructured":"19. East NCCH. 2020 [cited 2020 Jun 1]. Available from: https:\/\/www.ncc.go.jp\/jp\/ncce\/clinic\/palliative_care\/020\/index.html (in Japanese)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nakajima N, Abe Y. Concurrent specialized palliative care upon initiation of first-line chemotherapy for cancer progression: is it early enough? Am J Hosp Palliat Care 33: 340-345, 2016.","DOI":"10.1177\/1049909114560370"},{"key":"21","unstructured":"21. Japanese Society of Medical Oncology. Board certified fellow of the Japanese Society of Medical Oncology [Internet]. 2020 [cited 2020 Jun 5]. Available from: https:\/\/www.jsmo.or.jp\/system\/pdf\/senmon.pdf (in Japanese)."},{"key":"22","unstructured":"22. Japanese Society of Medical Oncology. Curriculum for diplomate. Subspecialty board of medical oncology, JSMO [Internet]. 2012 [cited 2020 Jun 1]. Available from: https:\/\/www.jsmo.or.jp\/authorize\/doc\/cal.pdf (in Japanese)."},{"key":"23","unstructured":"23. The Japanese Respiratory Society. Curriculum for board certified member of the Japanese Respiratory Society [Internet]. 2013 [cited 2020 Jun 1]. Available from: https:\/\/www.jrs.or.jp\/modules\/specialist\/index.php?content_id=11 (in Japanese)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Inoue A, Yamaguchi T, Tanaka K, et al. Benefits of a nationwide palliative care education program on lung cancer physicians. Intern Med 58: 1399-1403, 2019.","DOI":"10.2169\/internalmedicine.0872-18"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Hui D, Kim YJ, Park JC, et al. Integration of oncology and palliative care: a systematic review. The oncologist 20: 77-83, 2015.","DOI":"10.1634\/theoncologist.2014-0312"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hui D, Mori M, Watanabe SM, et al. Referral criteria for outpatient specialty palliative cancer care: an international consensus. Lancet Oncol 17: e552-e559, 2016.","DOI":"10.1016\/S1470-2045(16)30577-0"},{"key":"27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1634\/theoncologist.2016-0006","volume":"21","author":"D Hui","year":"2016","unstructured":"27. Hui D, Meng YC, Bruera S, et al. Referral criteria for outpatient palliative cancer care: a systematic review. The Oncologist 21: 895-901, 2016.","journal-title":"The Oncologist","ISSN":"https:\/\/id.crossref.org\/issn\/1083-7159","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/18\/60_6734-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T03:18:40Z","timestamp":1631935120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/18\/60_6734-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":27,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6734-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"article-number":"6734-20"}}